Cite Filings / EOLS
Feed Companies Filings Check
Sign in

CIK 0001570562 · Accelerated filer

Evolus, Inc.

Sign in to watch
Ticker
EOLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
461385614
Phone
(949) 284-4555
Business address
520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
Former names
Evolus, Inc.
Filings Insiders Search text
All 558 Financials 138 Shareholder Meetings 9 Executive Compensation 118 Insider Trading 252 Beneficial Ownership Interest 64 Business Combinations 100 Public Offerings 49 Mutual Funds and ETFs 8 Others 54
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-04-29
  3. DEF 14A Proxy Proxy Statement 2025-04-25
  4. DEF 14A Proxy Proxy Statement 2024-04-26
  5. DEF 14A Proxy Proxy Statement 2023-05-08
  6. PRE 14A Proxy Proxy Statement (Preliminary) 2023-04-26
  7. DEF 14A Proxy Proxy Statement 2022-04-29
  8. DEF 14A Proxy Proxy Statement 2021-04-26
  9. DEF 14A Proxy Proxy Statement 2020-03-17
  10. DEF 14A Proxy Proxy Statement 2019-04-29

Page 1 of 1 · 9 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…